Fresenius Kabi USA has initiated a voluntary nationwide recall of three lots of famotidine injection, USP 20 mg/2 mL (10 mg/mL, 2 mL vial), according to a company announcement posted on the FDA ...

Add Yahoo as a preferred source to see more of our stories on Google. Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2mL fill in a 2 mL vial recall Image by FDApress release A widely used ...

Famotidine 20mg/50mL; soln for IV infusion; preservative-free. Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity of ...

FOR IMMEDIATE RELEASE – Nov. 6,2025 – LAKE ZURICH, Ill.— Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration USFDA to market Famotidine Injection USP 40 mg4 mL 10 mgmL and 200 mg20 mL 10 mgmL multiple-dose ...

Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are being recalled in the U.S. by Fresenius Kabi. Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is voluntarily recalling three lots (numbers 6133156, 6133194, ...